Politics ❯Health Policy

Drug Regulation

FDA Public Health Healthcare Fraud Public Health Initiatives Weight Loss Drugs Lifestyle Choices Obesity Management Performance-Enhancing Drugs Healthcare Ethics FDA Oversight Cannabis Legislation Affordable Medications Pharmacy Oversight Lachgas Government Oversight Government Action Pricing Policies Federal Drug Commissioner Pharmaceutical Pricing

Delhi High Court Directs DCGI to Reassess Weight-Loss Drug Approvals Within Three Months

The court’s three-month deadline for a reasoned ruling aims to close regulatory gaps in off-label obesity treatments

Cologne Advances Ban on Nitrous Oxide Sales to Minors

Vancouver Pharmacists Challenge Sanctions Over Alleged Opioid Dispensing Misconduct

California Expands Access to Affordable Naloxone for Residents

Berlin Doctor Charged for Illegally Prescribing Addictive Painkiller

Donald Trump Jr. Invests in Controversial 'Enhanced Games' Allowing Performance-Enhancing Drugs

Elon Musk Promotes Weight-Loss Drug Mounjaro in Viral 'Ozempic Santa' Post

Study Promoting Hydroxychloroquine for COVID-19 Formally Retracted

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

Long Island Doctor Convicted of Illegally Prescribing Oxycodone for Cash

U.S. Obesity Rates Decline as Weight-Loss Drugs Gain Popularity